参考文献/References:
[1] 王荣福.肿瘤核素诊治现状与进展[J].同位素,2006,19(2): 112-118.
[2] Tumor JH,Martindale AA,Boucek J,et al.131I-Anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma:a phase Ⅱ clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital[J]. Cancer Biother Radiopharm,2003,18(4):513-524.
[3] Scott AM,Lee FT,Jones R.et al.A phase Ⅰ trial of humanized monoclonal antibody A33 in patients with eolorectal carcinoma: biodistribution,pharmacokineties,and quantitative tumor uptake[J].ClinCancerRes,2005,ll (13):4810-817.
[4] 王荣福.肿瘤受体显像//蒋宁一.肿瘤核医学[M].北京:人民卫生出版社.2002:256-268.
[5] Sward C,Bernhardt P,Johanson V,et al.Comparison of[1771u-DOTAO,Tyr3]-oetrotate and[1771u-DOTAO,Thy3]-oetemtide for receptor-meditated raditation therapy of the xenografted human midgut carcnoid tumor GOTl[J].Cancer Biother Radiopharm, 2008,23(1):114-120.
[6] Waldherr C,Pless M,Maecke HR.et al.The clinical value of -[90Y-DOTA]-D-PheI-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neurcendocrine tumors:a clinical phase Ⅱ study[J].Ann Oneol,2001,12(7):941-945.
[7] Schumaeher T,Hofer S,Eiehhorn K,et al.Local injiection of the 90Y-labelled pcptidic vector DOTATOC to control gliomas of WHO grades Ⅱ and Ⅲ: an extended pilot study[J].Ear J Nucl Med Mol Imaging,2002,29(4):486-493.
[8] Boland A,Ricard M,Opolon P,et al.Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy[J].Cancer Res,2000,60(13):3484-3492.
[9] Germarm C,Shields AF.Griersion JR,et al.5-Fluoro-1-(2’-deoxy-2’-fluoro-beta-D-ribofuranoayl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene[J].J Nucl Med,1998,39(8):1418-1423.
[10] Wagner HN Jr.2003 SNM Highlights Lecture:From proof of principle to proof of value[J].J Nuel Med,2003,44(8):11N-36N.
[11] xu MH,Zhang GY.Effect of indomethacin on cell cycle proteins in colon cancer celll lines[J].World J Gaatroenterol,2005,11(11):1693-1696.
[12] Mima S,Takehara M,Takada H,et al.NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells[J].Carcinogenesis,2008,29(10):1994-2000.
[13] Grégoire V,Hunter NR,Brock WA,et al.Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethaein plus fludarabine[J].Radiat Res,1996,146(5): 548-553.
[14] Kishi K,Petersen S,Petersen C,et al.Preferential enhancement of tumor radioresponse by a eyclooxygenase-2 inhibitor[J].Cancer Res,2000,60(5):1326-1331.
[15] 周丽坤,张彩霞.氚标记吲哚美辛的亲肿瘤实验研究[J].中华核医学杂志,2004,24(4):209-210.
[16] 陈春梅,张彩霞,刁尧,等.口引哚美辛对荷瘤小鼠抗肿瘤作用机制的实验研究[J].同位素,2006,19(1):22-27.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[10]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[11]杨坤禹,胡豫.抗肿瘤血管新生联合放射治疗研究进展[J].国际放射医学核医学杂志,2006,30(2):122.
YANG Kun-yu,HU Yu.The progress on anti-angiogenesis combined with radiotherapy in malignancies[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):122.